Skip to main content
NCBI home page
Transactions of the American Ophthalmological Society logoLink to Transactions of the American Ophthalmological Society
. 1979;77:225–279.

The eighth Frederick H. Verhoeff Lecture. presented by saiichi mishima, MD Behçet's disease in Japan: ophthalmologic aspects.

S Mishima, K Masuda, Y Izawa, M Mochizuki, K Namba
PMCID: PMC1311704  PMID: 397657

Abstract

The problems of Behçet's disease in Japan have been reviewed with particular emphasis on the ophthalmologic aspects: the historical background for the Japanese works, diagnostic critieria, epidemiology, some statistics, ocular symptomatology, ocular histopathology, etiology, pathophysiology, and treatment. Behçet's disease is the most frequent entity in endogenous uveitis in Japan. Patients are found throughout the country, and the prevalence rate averages seven to eight per 100,000 population: the rate is higher in the northern than in the southern districts. The diagnosis is made on the basis of a combination of clinical symptoms that are divided into the major and minor criteria symptoms. The major criteria comprise the ocular involvement, aphthous ulcers of the oral mucous membrane, genital ulcers, and skin lesions. These symptoms recur often as attacks and the disease follows a chronic course. The ocular involvement is found in 83% to 95% in males and 67% to 73% in females; the male to female ratio in the number of patients is 1.78. Both into the anterior segment type and the fundus and panophthalmic types. The anterior segment type shows serous iridocyclitis with the classic type of hypopyon appearing in about 12% of the attacks. This type is found in about 20%, more often in females than in males, and the visual prognosis is more favorable than in the fundus and panophthalmic types. In the latter two types, attacks of retinal angitis resulting in intensive retinal edema, yellowish-white exudate, and hemorrhages recur particularly in the macular region, and the visual prognosis is poor. More than 50% of male patients lose visual acuity to less than 0.1 in five years, but this is the case in only 10% of female patients. Consequently, Behçet's disease is the cause of blindness in about 12% of acquired blindness in adults. The ocular histopathology during the attack is characterized by severe angitis with intensive infiltration of neutrophil leucocytes largely in the uveal tract and the retina; the latter is severely affected and loss of visual cells and other neural elements results. The etiology of this disease still remains unknown but genetic predisposition is suggested since this disease is strongly linked with HL-A-B5. Environmental factors are also considered. Various abnormalities are found in the blood chemistry, blood cells (particularly in neutrophil leucocytes), immunologic mechanism, fibrinolytic and blood clotting system, and hormonal system. Chemotractic factors are found in the aqueous humor. These changes are particulary enhanced just before and during the ocular attacks. Systemic corticosteroids are deleterious to the visual prognosis, but cyclophosphamide and colchicine appear to suppress attacks and help patients maintain the visual acuity. However, these drugs are toxic, particulary to the reproductive organs, and the patients must be informed of this side effect and be allowed to make a decision before they are used.

Full text

PDF
279

Images in this article

242FIGURE 5
on p.242
243FIGURE 6
on p.243
244FIGURE 7
on p.244
245FIGURE 8
on p.245
246FIGURE 9
on p.246

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ADAMANTIADIS B. Recurrent uveitis. A new case of a complex syndrome. Am J Ophthalmol. 1951 Mar;34(3):447–449. [PubMed] [Google Scholar]
  2. Abdalla M. I., el-D Bahoat N. Long-lasting remission of Behcet's disease after chlorambucil therapy. Br J Ophthalmol. 1973 Sep;57(9):706–711. doi: 10.1136/bjo.57.9.706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aoki K., Fujioka K., Tagawa Y. [Meterological observation of ocular attacks in Behçet disease]. Nippon Ganka Gakkai Zasshi. 1972 Jan;76(1):26–32. [PubMed] [Google Scholar]
  4. Aoki K., Sugiura S. Immunosuppressive treatment of Behcet's disease. Mod Probl Ophthalmol. 1976;16:309–313. [PubMed] [Google Scholar]
  5. Araki Y. [Epidemiology and the present status of Behcet's syndrome]. Saishin Igaku. 1971 Mar;26(3):458–464. [PubMed] [Google Scholar]
  6. BOROS B., SEBESTYEN J. UBER DAS KLINISCHE UND HISTOLOGISCHE BILD DES BEH CET-SYNDROMS. Klin Monbl Augenheilkd. 1964 Oct;145:386–393. [PubMed] [Google Scholar]
  7. BRALEY A. E. A case of Behçet's disease. Trans Am Acad Ophthalmol Otolaryngol. 1958 Sep-Oct;62(5):712–715. [PubMed] [Google Scholar]
  8. BRESLIN H. J. Behcet's disease. Report of a case history of seventeen years' duration. Am J Ophthalmol. 1962 Jan;53:132–136. [PubMed] [Google Scholar]
  9. Bietti G. B., Cerulli L., Pivetti-Pezzi P. Behçet's disease and immunosuppressive treatment. Our personal experience. Mod Probl Ophthalmol. 1976;16:314–323. [PubMed] [Google Scholar]
  10. Brautbar C., Chajek T., Ben-Tuvia S., Lamm L., Cohen T. A genetic study of Behçet disease in Israel. Tissue Antigens. 1978 Feb;11(2):113–120. doi: 10.1111/j.1399-0039.1978.tb01234.x. [DOI] [PubMed] [Google Scholar]
  11. Chajek T., Fainaru M. Behçet's disease. Report of 41 cases and a review of the literature. Medicine (Baltimore) 1975 May;54(3):179–196. doi: 10.1097/00005792-197505000-00001. [DOI] [PubMed] [Google Scholar]
  12. Chamberlain M. A. Behcet's syndrome in 32 patients in Yorkshire. Ann Rheum Dis. 1977 Dec;36(6):491–499. doi: 10.1136/ard.36.6.491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Colvard D. M., Robertson D. M., O'Duffy J. D. The ocular manifestations of Behçet's disease. Arch Ophthalmol. 1977 Oct;95(10):1813–1817. doi: 10.1001/archopht.1977.04450100115015. [DOI] [PubMed] [Google Scholar]
  14. DOWLING G. B. Behcet's disease. Proc R Soc Med. 1961 Feb;54:101–104. [PubMed] [Google Scholar]
  15. EVANS A. D., PALLIS C. A., SPILLANE J. D. Involvement of the nervous system in Behçet's syndrome; report of three cases and isolation of virus. Lancet. 1957 Aug 24;273(6991):349–353. doi: 10.1016/s0140-6736(57)92589-8. [DOI] [PubMed] [Google Scholar]
  16. Ersoy F., Berkel I., Firat T., Kazokoğlu H. HLA antigens associated with Behçet's disease. Arch Dermatol. 1977 Dec;113(12):1720–1721. [PubMed] [Google Scholar]
  17. FENTON R. H., EASOM H. A. BEHCET'S SYNDROME. A HISTOPATHOLOGIC STUDY OF THE EYE. Arch Ophthalmol. 1964 Jul;72:71–81. doi: 10.1001/archopht.1964.00970020073018. [DOI] [PubMed] [Google Scholar]
  18. FRANCE R., BUCHANAN R. N., WILSON M. W., SHELDON M. B., Jr Relapsing iritis with recurrent ulcers of the mouth and genitalia (Behçet's syndrome); review: with report of additional case. Medicine (Baltimore) 1951 Dec;30(4):335–355. doi: 10.1097/00005792-195112000-00002. [DOI] [PubMed] [Google Scholar]
  19. FRANCOIS J. Les ectodermoses érosives pluriorificielles. Acta Ophthalmol (Copenh) 1954;32(1):5–36. doi: 10.1111/j.1755-3768.1954.tb07672.x. [DOI] [PubMed] [Google Scholar]
  20. Firat T. Results of immunosuppressive treatment in Bechçet's disease: report of 55 cases. Ann Ophthalmol. 1978 Oct;10(10):1421–1423. [PubMed] [Google Scholar]
  21. Fujiwara N., Ishikawa S. [Sural nerves in Behçet's disease--histopathological, electronmicroscopical and X-ray microanalytical studies (author's transl)]. Nippon Ganka Gakkai Zasshi. 1977 Nov 10;81(11):1733–1743. [PubMed] [Google Scholar]
  22. Godfrey W. A., Epstein W. V., O'Connor G. R., Kimura S. J., Hogan M. J., Nozik R. A. The use of chlorambucil in intractable idiopathic uveitis. Am J Ophthalmol. 1974 Sep;78(3):415–428. doi: 10.1016/0002-9394(74)90229-3. [DOI] [PubMed] [Google Scholar]
  23. HAENSCH R. Chronisch rezidivierende Aphthosis einschliesslich Behcets Trisymptomenkomplex. Arch Dermatol Syph. 1953;195(4):362–381. [PubMed] [Google Scholar]
  24. Hayasaka S., Hara S., Mizuno K. Lysosomal enzymes in the serum of patients with with Behçet's disease. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1977 Aug 8;203(2):139–144. doi: 10.1007/BF00413404. [DOI] [PubMed] [Google Scholar]
  25. Higuchi M., Sugiura S., Ohguchi M., Horimoto M., Yajima S., Kaneshima H., Naitoh M. [Some aspects of glycolytic enzyme activity of red blood cells in Behçet's disease (author's transl)]. Nippon Ganka Gakkai Zasshi. 1978 Jan 10;82(1):1–4. [PubMed] [Google Scholar]
  26. Hirohata T., Kuratsune M., Nomura A., Jimi S. Prevalence of Behçet's syndrome in Hawaii. With particular reference to the comparison of the Japanese in Hawaii and Japan. Hawaii Med J. 1975 Jul;34(7):244–246. [PubMed] [Google Scholar]
  27. Hori Y., Miyazawa S., Nishiyama S., Miyata M., Ishikawa S. Experimental Behçet's disease and ultrastructural X-ray microanalysis of pathological tissues. J Dermatol. 1979 Feb;6(1):31–37. doi: 10.1111/j.1346-8138.1979.tb01877.x. [DOI] [PubMed] [Google Scholar]
  28. Jung R. T., Chalmers T. M., Joysey V. C. HLA in Behçet's disease. Lancet. 1976 Mar 27;1(7961):694–694. doi: 10.1016/s0140-6736(76)92809-9. [DOI] [PubMed] [Google Scholar]
  29. Kalbian V. V., Challis M. T. Behçet's disease. Report of twelve cases with three manifesting as papilledema. Am J Med. 1970 Dec;49(6):823–829. doi: 10.1016/s0002-9343(70)80064-x. [DOI] [PubMed] [Google Scholar]
  30. Kogure M., Ono Y., Shimada K. [Immunological studies on uveitis by "six stages classification after tuberculin reaction and CH50" (author's transl)]. Nippon Ganka Gakkai Zasshi. 1977 Aug 10;81(8):1092–1100. [PubMed] [Google Scholar]
  31. MELCZER N. Note concerning the viral etiology of the Neumann's aphthous disease (ectodermosis pluri-orificialis, Stevens-Johnson disease, Behcet's triple symptom complex, dermato-stomatitis: its relation to erythema exudativum multiforme. Acta Med Acad Sci Hung. 1951;2(2):217–228. [PubMed] [Google Scholar]
  32. MORTADA A., IMAM I. Z. VIRUS AETIOLOGY OF BEH CET'S SYNDROME. Br J Ophthalmol. 1964 May;48:250–259. doi: 10.1136/bjo.48.5.250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. MULLER H. Zur Klinik und Histologie der rezidivierenden Hypopyon-Uveitis mit Angiitis obliterans der Retina. Klin Monbl Augenheilkd Augenarztl Fortbild. 1956;129(3):289–300. [PubMed] [Google Scholar]
  34. Mamo J. G., Azzam S. A. Treatment of Behçet's disease with chlorambucil. Arch Ophthalmol. 1970 Oct;84(4):446–450. doi: 10.1001/archopht.1970.00990040448008. [DOI] [PubMed] [Google Scholar]
  35. Mamo J. G. The rate of visual loss in Behçet's disease. Arch Ophthalmol. 1970 Oct;84(4):451–452. doi: 10.1001/archopht.1970.00990040453009. [DOI] [PubMed] [Google Scholar]
  36. Mamo J. G. Treatment of Behcet disease with chlorambucil. A follow-up report. Arch Ophthalmol. 1976 Apr;94(4):580–583. doi: 10.1001/archopht.1976.03910030274004. [DOI] [PubMed] [Google Scholar]
  37. Matsubara T., Eryu Y., Fukushiro R. [Prick test in Behçet's disease (author's transl)]. Nihon Hifuka Gakkai Zasshi. 1974 Nov;84(11):517–522. [PubMed] [Google Scholar]
  38. Matsumura N., Mizushima Y. Leucocyte movement and colchicine treatment in Behcet's disease. Lancet. 1975 Oct 25;2(7939):813–813. doi: 10.1016/s0140-6736(75)80031-6. [DOI] [PubMed] [Google Scholar]
  39. Mimura Y., Hoki T., Yuasa T., Moriyama H., Matsumoto K. [Studies on visual prognosis and its relationship to immunological behaviors of peripheral leucocytes and lymphocytes in Behçet disease (author's transl)]. Nippon Ganka Gakkai Zasshi. 1974 Jul 10;78(7):413–419. [PubMed] [Google Scholar]
  40. Nozik R. A., Godfrey W. A., Epstein W. V., O'Connor G. R., Kimura S. J., Hogan M. J. Immunosuppressive treatment of uveitis. Mod Probl Ophthalmol. 1976;16:305–308. [PubMed] [Google Scholar]
  41. Ohno S., Asanuma T., Sugiura S., Wakisaka A., Aizawa M., Itakura K. HLA-Bw51 and Behçet's disease. JAMA. 1978 Aug 11;240(6):529–529. [PubMed] [Google Scholar]
  42. Okinami S., Hayashi M., Uyama M. [HLA antigens in the patients with Behcet's disease, sarcoid-uveitis, and endogeneous uveitis (author's transl)]. Nippon Ganka Gakkai Zasshi. 1977 Jan 10;81(1):43–47. [PubMed] [Google Scholar]
  43. Oniki S. [Pathogenesis and treatment of Behcet's disease]. Nippon Ganka Gakkai Zasshi. 1974 Nov 10;78(11):1347–1378. [PubMed] [Google Scholar]
  44. Ono S., Aoki K., Sugiura S., Nakayama E., Itakura K. [Immunohematological studies on Behçet's disease. Histocompatibility (HL-A) antigens and I blood group system (author's transl)]. Nippon Ganka Gakkai Zasshi. 1973 Sep;77(9):1452–1460. [PubMed] [Google Scholar]
  45. Ono S., Nakayama E., Sugiura S., Itakura K., Aoki K. Specific histocompatibility antigens associated with Behçet's disease. Am J Ophthalmol. 1975 Oct;80(4):636–641. doi: 10.1016/0002-9394(75)90394-3. [DOI] [PubMed] [Google Scholar]
  46. Oshima Y., Shimizu T., Yokohari R., Matsumoto T., Kano K., Kagami T., Nagaya H. Clinical Studies on Behçet's Syndrome. Ann Rheum Dis. 1963 Jan;22(1):36–45. doi: 10.1136/ard.22.1.36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. PHILLIPS D. L., SCOTT J. S. Recurrent genital and oral ulceration with associated eye lesions; Behçet's syndrome. Lancet. 1955 Feb 18;268(6860):366–371. doi: 10.1016/s0140-6736(55)91268-x. [DOI] [PubMed] [Google Scholar]
  48. Polychronakos D. J., Sarakotsis G. P. Das Adamantiadis-Behçet-Syndrom. Klin Monbl Augenheilkd. 1969 Mar;154(3):336–341. [PubMed] [Google Scholar]
  49. Rosselet E., Saudan Y., Jeannet M. Recherche des antigènes HL-A dans la maladie de Behçet. Ophthalmologica. 1976;172(2-3):116–119. doi: 10.1159/000307680. [DOI] [PubMed] [Google Scholar]
  50. Rosselet E., Saudan Y., Zenklusen G. Les effets de l'azathioprine ("Imuran") dans la maladie de Behçet. Premiers résultats thérapeutiques. Ophthalmologica. 1968;156(3):218–226. doi: 10.1159/000305426. [DOI] [PubMed] [Google Scholar]
  51. SCHRECK E. Uber einander zugeordnete Erkrankungen der Haut, der Schleimhäute und der Deckschicht des Auges (cutaneo-muco-oculoepitheliale Syndrome). Arch Klin Exp Dermatol. 1954;198(3):221–257. [PubMed] [Google Scholar]
  52. SEZER F. N. The isolation of a virus as the cause of Behcet's diseases. Am J Ophthalmol. 1953 Mar;36(3):301–315. doi: 10.1016/0002-9394(53)91372-5. [DOI] [PubMed] [Google Scholar]
  53. STUCCHI C., VOLLENWEIDER A. Maladie de Behçet et manifestations atypiques. Ophthalmologica. 1958 May-Jun;135(5-6):573–578. doi: 10.1159/000303354. [DOI] [PubMed] [Google Scholar]
  54. Saito K., Higuchi M., Sugiura S. [Studies on blood coagulability activity in Behçet's disease (author's transl)]. Nippon Ganka Gakkai Zasshi. 1976 Jan 10;80(1):1–6. [PubMed] [Google Scholar]
  55. Saito K., Ohguchi M., Sugiura S. [The autonomic nervous system in Behçet's disease (author's transl)]. Nippon Ganka Gakkai Zasshi. 1975 Dec 10;79(12):1835–1839. [PubMed] [Google Scholar]
  56. Saito K. [Studies on fibrinolytic activity in Behçet's disease. 3. An approach by affinity chromatography (author's transl)]. Nippon Ganka Gakkai Zasshi. 1973 Sep;77(9):1443–1451. [PubMed] [Google Scholar]
  57. Sanefuji M. [Cell-mediated immunity in uveitis. 3. Leukocyte migration inhibition test in Behçet disease (author's transl)]. Nippon Ganka Gakkai Zasshi. 1974 Jul 10;78(7):408–412. [PubMed] [Google Scholar]
  58. Shibuya E., Masuda K., Izawa Y. Effects of prostaglandins on leukocyte migration. Prostaglandins. 1976 Aug;12(2):165–174. doi: 10.1016/0090-6980(76)90110-6. [DOI] [PubMed] [Google Scholar]
  59. Shibuya E. [Chemotactic activity in the aqueous humor of patients with Behçet's disease (author's transl)]. Nippon Ganka Gakkai Zasshi. 1973 Sep;77(9):1434–1442. [PubMed] [Google Scholar]
  60. Shimada K., Kogure M., Kawashima T., Nishioka K. Reduction of complement in Behçet's disease and drug allergy. Med Biol. 1974 Aug;52(4):234–239. [PubMed] [Google Scholar]
  61. Shimizu K. [Fluorescein fundus angiography in Behcet's syndrome]. Nippon Ganka Gakkai Zasshi. 1970 Oct;74(10):1432–1448. [PubMed] [Google Scholar]
  62. Shimizu T. [Clinical and immunological studies on Behçet's syndrome]. Nihon Ganka Kiyo. 1971 Oct;22(10):801–810. [PubMed] [Google Scholar]
  63. Smulders F. M., Oosterhuis J. A. Treatment of Behcet's disease with chlorambucil. Ophthalmologica. 1975;171(4-5):347–352. doi: 10.1159/000307544. [DOI] [PubMed] [Google Scholar]
  64. Sugiura S., Aoki K., Fujioka K., Kono M., Sakurada N. [Serum antibodies to various pathogenic agents and lymphocytic transformation in Behçet disease]. Nippon Ganka Gakkai Zasshi. 1972 Aug;76(8):635–641. [PubMed] [Google Scholar]
  65. Sugiura S., Sanefuji M., Ohno S. Immunological studies on Behçet's and Harada's diseases. I. Cell-mediated immunity in Behçet's and Harada's diseases. II. HL-A antigens associated with Behçet's disease. Mod Probl Ophthalmol. 1976;16:267–278. [PubMed] [Google Scholar]
  66. Sugiura S. [Some observations on uveitis in Japan, with special reference to Vogt-Koyanagi-Harada and Behçet diseases (author's transl)]. Nippon Ganka Gakkai Zasshi. 1976 Nov 10;80(11):1285–1326. [PubMed] [Google Scholar]
  67. THOMAS E. W. P. So-called triple-symptom complex of Behçet. Br Med J. 1947 Jan 4;1(4487):14–16. doi: 10.1136/bmj.1.4487.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Takano M., Miyajima T., Kiuchi M., Ohmori K., Amemiya H. Behçet disease and the HLA system. Tissue Antigens. 1976 Aug;8(2):95–99. [PubMed] [Google Scholar]
  69. Tricoulis D. Treatment of Behcet's disease with chlorambucil. Br J Ophthalmol. 1976 Jan;60(1):55–57. doi: 10.1136/bjo.60.1.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Urayama A., Sakuragi S., Takahashi N., Sakai F., Tanaka Y. [Etiology and treatment of Behcet's disease]. Nippon Ganka Gakkai Zasshi. 1974 Nov 10;78(11):1304–1346. [PubMed] [Google Scholar]
  71. ZEAVIN B. H., KING M. J., GOHD R. S. A case of Behçet's disease. Am J Ophthalmol. 1956 Jan;41(1):55–60. doi: 10.1016/0002-9394(56)91462-3. [DOI] [PubMed] [Google Scholar]

Articles from Transactions of the American Ophthalmological Society are provided here courtesy of American Ophthalmological Society

RESOURCES